HISTOPATHOLOGICAL AND BIOCHEMICAL CHANGES OF ACUTE KETOPROFEN INDUCED NEPHROPATHIC LESIONS IN RATS

Authors

Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, Assuit University, Egypt.

Abstract

ABSTRACT
 
The current work was undertaken to evaluate the nephrotoxic effect of Ketoprofen on adult male rats. Eighteen rats were divided into two groups. Ketoprofen- received group (I) included 10 rats were administered Ketoprofen at a therapeutic dose of 13.5 mg/kg by I/M injection daily for 4 successive weeks. Five rats were randomly selected from group I and sacrificed at 2 and 4 weeks of the experiment. The control group (II) that received olive oil included 8 rats, where 4 rats were sacrificed after2 weeks and the rest of rats were sacrificed after 4 weeks. Tissue specimensfrom kidneys of all groups were collected for histopathological examination as well as the serum was obtained for the determination of biochemical parameters. The histopathological examination of group I showed glomerular changes such as expanding of glomerular matrix, glomerular sclerosis and congestion of glomerular capillary in the cortex. Renal tubular degeneration and necrosis accompanied with infiltration of inflammatory cells in interstitial tissue in both cortex and medulla were also observed. The biochemical results revealed that animals in group I showed a significant increase in malondialdehyde, creatinine, and urea compared to the control group, while total antioxidant capacity was numerically decreased. In conclusion, the therapeutic dose of Ketoprofen caused damage in kidney tissue even if was taken for a short period as well as altered biochemical parameters.

Keywords


Assiut University web-site: www.aun.edu.eg

 

HISTOPATHOLOGICAL AND BIOCHEMICAL CHANGES OF ACUTE KETOPROFEN INDUCED NEPHROPATHIC LESIONS IN RATS

 

AMIRA S. SADEK; MARWA F. ALI; SARY K. ABD ELGHFAR and

MOKHTAR TAHA

Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine,

Assuit University, Egypt.

 

Received:4April 2021;     Accepted:30 April 2021

 

 

ABSTRACT

 

The current work was undertaken to evaluate the nephrotoxic effect of Ketoprofen on adult male rats. Eighteen rats were divided into two groups. Ketoprofen- received group (I) included 10 rats were administered Ketoprofen at a therapeutic dose of 13.5 mg/kg by I/M injection daily for 4 successive weeks. Five rats were randomly selected from group I and sacrificed at 2 and 4 weeks of the experiment. The control group (II) that received olive oil included 8 rats, where 4 rats were sacrificed after2 weeks and the rest of rats were sacrificed after 4 weeks. Tissue specimensfrom kidneys of all groups were collected for histopathological examination as well as the serum was obtained for the determination of biochemical parameters. The histopathological examination of group I showed glomerular changes such as expanding of glomerular matrix, glomerular sclerosis and congestion of glomerular capillary in the cortex. Renal tubular degeneration and necrosis accompanied with infiltration of inflammatory cells in interstitial tissue in both cortex and medulla were also observed. The biochemical results revealed that animals in group I showed a significant increase in malondialdehyde, creatinine, and urea compared to the control group, while total antioxidant capacity was numerically decreased. In conclusion, the therapeutic dose of Ketoprofen caused damage in kidney tissue even if was taken for a short period as well as altered biochemical parameters.

 

Keywords:Ketoprofen, Nephrotoxicity, Histopathological examination, Biochemical parameters.

 

 


INTRODUCTION

 

Ketoprofen is known as 2-(3-benzoylphenyl)-propionic acid. It is derived from arylpropionic acid class of nonsteroidal anti-inflammatory drugs (NSAIDs) (Caldwell et al., 1988). Ketoprofenis white or off-white in colour,

 

 


Corresponding author:AMIRA S. SADEK

E-mail address:amira.sayed4494@gmail.com

Present address:Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine,

Assuit University, Egypt.

odourless, fine to a granular powder, highly lipophilic, soluble in strong alkali and also easily soluble in ethanol, chloroform, acetone, and ether, but it is insoluble in water at 20°C (Klasco, 2003).

 

Ketoprofen possesses good anti-inflammatory, antipyretic, and analgesic effects(Seymour et al., 1996; Levoinet al., 2004).Ketoprofen can be used in the treatment of rheumatic diseases such as rheumatoid arthritis and osteoarthritis (Medeiroset al., 2020).

It is considered an essential part of current veterinary therapy, it can relieve pain and inflammation associated with musculoskeletal disorders in dogs, cats, horses and cattle, and it alleviates fever in acute mastitis in cattle (Shpigelet al.,1994; Owens et al., 1995; Arrioja-Dechert, 2002; Grecuet al., 2014). In addition,Ketoprofenhelps in reducing joint swelling and works as a medication for arthritis (Zafaret al., 2017).

 

Although Ketoprofen is regarded as a wide therapeutic drug, it may cause unwanted side effects(Villegaset al., 2004). The side effects of Ketoprofen have resembled other NSAIDs(Fries et al., 1993).Most of the patients administrated therapeutic doses of Ketoprofen for a short duration usually tolerate them well, but, with longer duration of treatment may cause the occurrence of high risk(Bennett et al., 1996; Harirforooshet al., 2013).Ketoprofen can cause various forms of renal damage as acute kidney injury, renal papillary necrosis, acute interstitial nephritis, hyperkalemia, and sodium and fluid retention(Breyer and Harris, 2001). Furthermore, there were histopathological changes related to administration of Ketoprofen therapeutic dose such as atrophy and congestion in few glomeruli, degeneration of renal tubules and interstitial nephritis (Farag Allah, 2001).

 

The present studydeterminedthe nephrotoxic effect of administration of atherapeutic dose of Ketoprofen for 2and 4 weeks. This was done via histopathological examination of kidney tissue sections, estimation ofoxidative indices (total antioxidant capacity and lipid peroxidation) and kidney functions through detection of creatinine and urea in the blood.

 

MATERIALS AND METHODS

 

Materials:

Chemicals used:

Ketoprofen: Purchased from SIGMA Aldrich (St Louis, MO, USA).

Total antioxidant capacity (TAC) kit, Malondialdehyde (MDA) kit, Urea kitand Creatinine kit, were purchased fromBiodiagnostic Company, Egypt.

 

Experimental animals:

Eighteen adult male rats were obtained from the Laboratory Animal House, Faculty of Vet. Medicine, Assiut University. The rats were healthy, weighing about 180-200gms. The animals were housed in cages under controlled temperature (25C°) and humidity. All animals received laboratory food and tap water ad libitum. They were housed in the laboratory for at least one week before the experiment for acclimatization. The time of the experiment was 4 weeks. The rats were randomly divided into 2 groups according to the following design:

 

Group 1:Ketoprofenadministered rats:

Ten adult male rats were givenKetoprofenin a dose of 13.5 mg/kg(Farag Allah, 2001). Ketoprofenwas dissolved in olive oil and given by I/M injection daily for 4 successive weeks.After 2 weeks, 5 rats were randomly selected and sacrificed by cervical dislocation, while the other 5 rats were sacrificed after 4 weeks.

 

Group 2: Control rats:

Eight ratswere given only Ketoprofen vehicle (olive oil) in a similar dose and route of Ketoprofen administered group. Four ratswere sacrificed after2 weeks and the others were sacrificed after 4 weeks.

 

Methods:

Histopathological examination:

After sacrificing the rats from different groups according to the assigned schedule, kidney tissue specimenswere collected and fixed in 10% neutral buffered formalin solution for 24 hours and then routinely processed for conventional histopathological examination as follow:

 

Tissue specimens were washed in tap water and then kept in 70% ethyl alcohol overnight. Dehydration of the specimens was done by immersion in ascending grades of ethyl alcohol (70%, 80%, 90% and 100%) for a half-hour each. Tissue specimens were cleared with xylene and embedded in paraffin wax and then blocked by fresh molten paraffin. Five-micron sections were cut and stained with hematoxylin and eosin stain (Bancroft and Stevens, 1982) for histopathological examination by light microscopy (Olympus CX31, Japan) with Digital Camera(Olympus Cameda C -5060, Japan).

 

Histopathological scoring:

All the microscopic lesions of the kidney for each group were presented in tables to demonstrate the type of lesion and its severity according to (Chen et al., 2018)as follow:

 

Kidney lesions ranged from 0 to 4. Histopathological score is (0 = no lesions), (1= mild), (2= moderate), (3= severe) and (4= very severe lesions).

 

  • Glomerular lesions:Histological injury of glomeruli was estimated as the percentage of glomeruli that showed glomerular congestion, glomerulosclerosis, glomerular collapse and glomerular basement membrane expansion. In each round of the experiment, 10 glomeruli were randomly selected in cortical fields and evaluated atbar =100umin each kidney section, and an average score was calculated.

 

  • Tubular lesions:Histological injury of renal tubules was evaluated as the percentage of tubules that showed tubular dilation, tubular atrophy, tubular epithelial cell necrosis and cast formation. At bar =100 umin each kidney section. Ten areas of renal tubules were randomly chosen per kidney for the assessment, and an average score was calculated in each round of the experiment.
  • Tubulointerstitial lesions:Tubulointerstitialinjury was scored according to the degree of intertubular congestion and area of infiltration of inflammatory cells. A score of 0 was assigned when the section shows no damage, a score of 1 was assigned when less than 25% was present, a score of 2 was assigned when there was at least 50% but less than 75%, a score of 3 was assigned when there was at least 76% but less than 95%, and finally a score of 4 was assigned when there was at least 95%. At bar =100 um, the severity of tubulointerstitial injury was evaluated by examining 10 randomly selected fields in each kidney section stained with H&E in each round of the experiment.

 

Biochemical estimations:

Blood samples were taken from the medial canthus of the eye and collected in sterilized plain tubes (without anticoagulant) from all experimental animals before sacrificing. Bloodsamples were centrifuged then sera were separated by micropipette into epindorf tubes from all different groups and kept frozen at -20 °C till the time of estimation of the biochemical parameters.

 

Biochemical parameters were measured in the Central Laboratory of Pathology and Clinical Pathology Department, Faculty of Veterinary Medicine, Assiut University by using of 6705 UV |Vis Spectrophotometer (JENWAY) as the following:

 

1-Total antioxidants capacity (TAC) was determined using a colourimetric assay kit according to (Koracevicet al., 2001).

 

2-Malondialdehyde (MDA) was determined using a colourimetric assay kitaccording to (Ohkawaet al., 1979).

 

3- Urea was determined using a colourimetric assay kit according to (Fawcett and Soctt, 1960).

4-Creatininwas determined using colourimetric assay kit according to (Larsen, 1972).

 

Statistical analysis:

The data were analyzed using the Statistical Package for Social Science programSPSS (version 16) software. For comparison between different experimental groups, one-way analysis of variance(one-way ANOVA) was used followed by the Duncan test as a Post Hoc test. The graphs were done by using the Prism program, version 5.01 (GraphPad Prism).The acceptance level for statistical significance was P < 0.05. All data were expressed as mean ± S.E.

 

RESULTS

 

Histopathological findings:

Group I: Rats sacrificed 2 weeks post Ketoprofen administration:

Microscopic examination of H&E stained tissue sections from the kidneys of the sacrificedrats administered Ketoprofen for 2 weeks revealed marked nephropathic lesions in both cortex and medulla. The cortical lesions could be classified into glomerular, tubular and interstitial lesions.

 

Consistent glomerular changes appeared in all 5 examined rats and affected the majority of the glomeruli. These changes were expressed by swelling of the glomerular tufts of capillaries with complete obliteration of Bowman's space. These swollen glomeruli were related to either expanded mesangial matrix with thickening of the glomerular basement membrane (Fig. 1a). The glomerular changes were associated with occasional congestion of the glomerular capillary tufts. Furthermore, periglomerular mononuclear cellular infiltration appeared in all 5 examined rats that exhibited focal distribution (Fig. 1b). On the contrary, focal glomerular atrophy was seen in 2 rats. The atrophied glomeruli appeared shrunken with widened Bowman’s space, decrease in the mesangial matrix and mesangial cells (Fig. 1c).

 

Microscopic examination of the cortical renal tubules showed variable forms of tubulonephrosis.Apoptosis of the renal tubular epithelium was a peculiar finding in 2 rats out of the 5 rats. The apoptotic cells were demonstrated as sporadic shrunken cells with dense nuclear fragments, eosinophilic cytoplasm, compact nuclear chromatin and surrounded by a clear halo. The diagnosed apoptotic changes were accompanied by haemoglobinnephrosiswhere an accumulation of eosinophilic pigment in the tubular epithelial cells was also found in 2 rats out of the 5 rats in a focal manner (Fig. 1d).

 

The angiopathic changes of the cortical interstitial tissue appeared in all 5 rats. These changes were manifested as congestion of the blood vessels, vacuolation of tunica media, desquamation of the vascular endothelium and perivascular infiltration of mononuclear inflammatory cells (Fig. 1e).

 

Regarding the vascular damage seen in the renal medulla, severe congestion was found in all examined cases. Besides, edema of the interstitial stroma was noticed as faint pink homogenous fluid infiltrated with mononuclear inflammatory cellular reaction in only 2 rats. Focal atrophy of the collecting tubules was evident in 2 rats out of the 5 examined cases (Fig. 1f).

 

Rats sacrificed 4 weeks post Ketoprofen administration:

Histopathological examination of these rats showed various nephropathic alterations that affected the glomeruli. These alterations were expressed by focal periglomerular mononuclear cellular infiltration that appeared in all 5 examined rats (Fig. 2 a).

 

Focal global glomerulosclerosis was a distinctive glomerular finding revealed in 3 rats out of the 5 rats and it affected some glomeruli. The characteristic features of this lesion included replacement of mesangium with fibrosis, increase in the glomerular matrix; obliteration of the capillary lumen and hypocellularity, also, it was accompanied by intertubularhaemorrhage that expressed in all examined rats (Fig. 2 b).In all 5 examined rats other glomerular lesions which involved most of the glomeruliwere demonstrated. These lesions were manifested by dilatation and congestion of the glomerular tufts of capillaries, accompanied by complete obliteration of Bowman's space as a result of an expanded mesangial matrix with thickening of the glomerular basement membrane. These diagnostic glomerular lesions were associated with intertubular congestion in all 5 examined rats (Fig. 2c).

 

Another prominent finding, revealed in 3 rats out of 5 rats, was focal segmental glomerulosclerosis. Histologically, it was characterized by segments of sclerosis, obliteration of glomerular capillary lumen and an increase in glomerular matrix of some glomeruli that was accompanied with thickening in glomerular basement membrane without obliteration of urinary space (Fig. 2d). Periglomerularhaemorrhage was found in 2 rats out of 5 examined rats affecting few glomeruli (Fig. 2e). Focal collapsing of glomerular segment causing a decrease in the glomerular matrix was also seen in 2 rats out of 5 rats, associated with intertubularhaemorrhage (Fig. 2f).

 

A diffuse vacuolar degeneration was commonly observed in the cortical convoluted tubules and collecting ducts of all examined rats. It was characterized by cellular swelling and clear vacuoles present in the cytoplasm of renal tubular epithelium. This feature was associated with mononuclear inflammatory cells infiltration in the interstitium and some tubular lumina contained sloughed cellular debris that caused occlusion of tubular lumen forming epithelial cast (Fig. 3a). Hyaline cast formation was seen in 3 rats out of 5 rats. This intratubular cast appeared as an eosinophilic proteinaceous homogenous cast associated with cellular flattening and irregularity of the lining epithelium (Fig. 3b).

 

The vascular changes were also revealed in all examined rats as perivascular mononuclear cellular infiltration, vacuolation of tunica media and desquamation of vascular endothelium. These vascular changes were accompanied by perivascular edema admixed with red blood cells (RBCs) and infiltrated with inflammatory cells that appeared in 2 rats out of 5 rats (Fig. 3c).

 

Histopathological examination of the renal medulla in all examined rats revealed morphological alterations in various segments of medullary tubules. These alterations were expressed by clear cytoplasmic vacuolar degeneration in renal tubular epithelium of the collecting ducts (Fig. 3d). Focal dystrophic calcification of medullary tubules accompanied the medullary tubular injury and was seen in 2 rats out of 5 rats as purple calcium deposits on the necrotic tubular epithelium. It was associated with intraluminal pale eosinophilic proteinaceous material (Fig. 3e). Moreover, focal intraluminal pale eosinophilic proteinaceous material associated with congestion in intertubular blood vessels were persistent lesions in the medullary tubules of all 5 examined rats (Fig. 3f).

 

Group II: Control group:

Histopathological examination of the renal tissue of the control rats showed normal histological structure. The normal glomeruli had thin glomerular capillary loops and cellular constituent. The surrounding different types of renal tubules appeared normal without changes in the interstitial tissue (Fig. 4 a & b).

 

Results of histopathological scoring:

Histopathological scorings were carried out in the cortex and medulla using H&E stained tissue sections from the kidneys of rats administered Ketoprofenfor 2 and 4 weeks as well as the control rats.

 

Histopathological scoring of rats sacrificed 2 and 4 weeks post Ketoprofenshowed a significant increase in the glomerular, tubular, interstitial lesions compared with the control values.

 

The histopathological scoring of renal lesions in different groups was demonstrated in Table (1) and Graph (1).

 

Biochemical results:

Kidney function parameters (creatinine and urea levels):

Serum biochemical analysis of Ketoprofen administered group for 2 weeks showed significantly changed values of urea and creatinine levels. Ketoprofen administered group showed a significant increase in the level of serum urea and creatinine when compared with the control group.

 

Evaluation of kidney function parameters of rats administered Ketoprofen for 4 weeks revealed a significant increase in serum urea concentration in comparison with the control group.  Regarding the serum level of creatinine, there was a significant increase in Ketoprofen administered group as compared with the control one. Creatinine and urea levels in rats of different groups were demonstrated in Table (2) and Graph (2, 3, 4 and 5).

 

Oxidative stress indices (MDA and TAC):

Determination of serum levels of MDA and TAC exhibited that there was a significant elevation in the level of MDA inKetoprofen administered group after 2 weeks compared with the control one, but the serum level of TAC in Ketoprofen administrated group after 2 weeks was numerically decreased in comparison with control group. There was a significant increase in the serum level of MDA in Ketoprofen administered group after 4 weeks compared to the control one, however, the serum level of TAC was numerically decrease compared to the control group.

 

Selected biochemical parameters in rats of different groups were presented in Table (3) and Graph (6).

 

 

 

 

 

Fig. 1: Kidney, Ketoprofen administered group after 2 weeks showing (a) An expanded mesangial matrix with thickening of glomerular basement membrane and obliteration of Bowman's space (star). (b) Congestion of glomerular capillary (arrow) and periglomerular mononuclear cellular infiltration (star). (c) Shrunken glomeruli with widened of the Bowman’s space (arrow). (d) Apoptotic cells (apoptosis) (arrow) and haemoglobinnephrosis (arrow head). (e) Congestion of blood vessels (arrow head), perivascular mononuclear cellular infiltration (star), vacuolation of tunica media (arrow), and desquamation of vascular endothelium (notched arrow). (f) Interstitial edema (star) with tubular atrophy (arrow) and congestion of intertubular blood vessels (arrow head) (H&E, bar= 20 um).

 

 

 

 

Fig. 2: Kidney, Ketoprofen administered group after 4 weeks showing (a) Periglomerular mononuclear cellular infiltration (star). (b) Focal global glomerulosclerosis (star) and intertubularhaemorrhage (arrow). (c) Congestion of glomerular capillary tufts (arrow head), expanded mesangial matrix (star) with thickening of glomerular basement membrane, obliteration of Bowman's space (arrow) and congestion of intertubular blood vessels (notched arrow). (d)Focal segmental glomerulosclerosis accompanied with thickening in glomerular basement membrane (arrow). (e) Periglomerularhaemorrhage (star). (f) Collapsing glomerular segment (arrow) and intertubularhaemorrhage (notched arrow) (H&E, bar= 20 um).

 

 

 

 

 

 

Fig. 3:Kidney, Ketoprofen administered group after 4 weeks showing (a) Vacuolar degeneration of renal tubular epithelium (arrow), epithelial casts formation (notched arrow) and interstitial infiltration with mononuclear inflammatory cells (star). (b) Hyaline cast in renal tubular lumen (arrow). (c) Perivascular mononuclear cellular infiltration (star), vacuolation of tunica media (arrow), desquamation of vascular endothelium (notched arrow) and perivascular edemaadmixed with (RBCs)and infiltrated with inflammatory cells (arrow head). (d) Vacuolar degeneration in renal medullary tubules (arrow). (e) Dystrophic calcification in renal tubules (arrow) associated with intraluminal pale eosinophilic proteinaceous material (star). (f)Focal intraluminal pale eosinophilic proteinaceous material (star) and congestion in intertubular blood vessels (arrow head) (H&E, bar= 20 um).

 

 

 

Fig.4: Kidney cortex, control rats showing (a) normal glomeruli (star).  (b) Kidney medulla, control rats showing normal medullary tubule(arrow)(H&E, bar= 20 um).

 

Table 1:Histopathological score (scale 0-4) of renal lesions observed by light microscopy in the kidney of rats Ketoprofen 2 weeks administered group, Ketoprofen 4 weeks administered group and control rats.

 

Renal lesions

Ketoprofen 2 weeksadministered group

Ketoprofen 4 weeksadministered group

Control rats

Glomerular lesions

3.60±0.24a

4.00±0.00a

0.60±0.24b

Tubular lesions

3.20±0.37a

4.00±0.00a

0.60±0.24b

Interstitial lesions

3.40±0.24a

4.00±0.00a

0.60±0.24b

 

Means within the same row with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

Table 2:Values of Kidney function parameters (creatinine and urea levels) in rats of different groups.

 

 

Ketoprofen2 weeks administered group

Ketoprofen 4 weeks administered group

Control rats

Urea

(mg/dl)

64.43± 3.70a

68.84±4.87a

35.45±1.86b

Creatinine (mg/dl)

2.15±0.30a

1.58±0.06a

1.11±0.05b

 

Means within the same row with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

Table 3:Values of biochemical indices (MDA and TAC levels) in rats of different groups.

 

 

Ketoprofen 2 weeks administered group

Ketoprofen 4 weeks administered group

Control rats

MDA

(nmol/ml)

6.75± 0.61a

16.89±1.85a

2.19±0.43b

TAC (mM/L)

1.13±0.25a

1.29±0.05a

1.48±0.21a

 

Means within the same row with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

Graph (1): Histopathological score (scale 0-4) of renal lesions in Ketoprofen administered group and control group after 2 and 4 weeks. Means with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± SE.

 

Graph (2): Values of urea (mg/dl) in Ketoprofen administered group and control group after 2 weeks. Means with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

 

Graph (3): Values of creatinine (mg/dl) in Ketoprofen administered group and control group after 2 weeks. Means with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

Graph (4): Values of urea (mg/dl) in Ketoprofen administered group and control group after 4 weeks. Means with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

Graph (5): Values of creatinine (mg/dl) in Ketoprofen administered group and control group after 4 weeks. Means with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 

Graph (6): Values of MDA (nmol/ml) and TAC (mM/L) in Ketoprofen administered group and control group after 2 and 4 weeks. Means with different superscripts were significantly different at P< 0.05. Data were expressed as the mean ± S.E.

 


DISCUSSION

 

In our study, we investigated the effect of a therapeutic dose of Ketoprofen on renal tissue in rats administered Ketoprofen in a dose of 13.5 mg/kg daily by intramuscular route for 4 weeks (Farag Allah, 2001). The rats were sacrificed 2 and 4 weeks post-dosing beside the control group. Tissue specimens from the kidneys were taken and subjected for histopathological examination as well as the serum was collected for biochemical analysis in the Ketoprofen administered group and control group.

 

Histopathological findings of tissue sections from the kidneys of the sacrificed rats administered Ketoprofen for 2 weeks revealed marked nephropathic lesions in both cortex and medulla. The cortical lesions could be classified into glomerular, tubular and interstitial lesions.

 

Concerning the glomerular lesions observed in our study, there were congestion of the glomerular capillary tufts,expanded mesangial matrix with thickening of the glomerular basement membrane, focal glomerular atrophy and periglomerular mononuclear cellular infiltration. Similar glomerular lesions were described bymany authors (Tomic et al., 2008; Awadet al., 2014; El-Fekyet al., 2018).

 

In our work, there were variable forms of tubulonephrosisin the cortex as apoptosis of the renal tubular epithelium and haemoglobinc nephrosis. In addition to interstitial lesions expressed by congestion of the blood vessels, vacuolation of tunica media, desquamation of the vascular endothelium and perivascular infiltration of mononuclear inflammatory cells. Moreover, the medulla was also affected including interstitial edema, tubular atrophy and congestion of intertubular blood vessels. Similar results were previously described and interpreted by Farag Allah(2001) who studied the effects of different doses of Ketoprofen in various periods on renal tissue.

 

Kentet al. (2007)reported on the similar effect of Ibuprofen in neonatal rats. Deniz (2019) proved that Ketoprofen can increase caspase-3 activity which is critical in inducing apoptosis of pancreatic cells. On the other hand, Safarchiet al. (2010) revealed only interstitial nephritis and glomerular hypercellularity in goats administered Flunixinmeglumine, Ketoprofen, and Phenylbutazone.Mozaffariet al. (2010)stated thatKetoprofen caused only interstitial nephritis in miniature donkeys.

 

Regarding our histopathological observation after administration of Ketoprofen for 4 weeks, various morphopathological alterations of the glomeruli were manifested as focal segmental glomerulosclerosis, focal global glomerulosclerosis, congestion of the glomerular tufts of capillaries, expanded mesangial matrix with thickening of glomerular basement membrane and focal collapsing glomerular segment. The same glomerular changes were recorded by (Farag Allah, 2001). Furthermore, these findings could be supported byMozaffari andDerakhshanfar (2011) who reported that administration of NSAIDs as Flunixinmeglumine, Ketoprofen, and Phenylbutazonein fat-tailed sheep caused similar results such as glomerular sclerosis and glomerular hypercellularity.

 

Variable changes were also seen in the renal tubules of rats sacrificed 4 weeks post-dosing. These changes were expressed by vacuolar degeneration, interstitial infiltration with mononuclear inflammatory cells, epithelial cast, hyaline cast formation and perivascular edema admixed with RBCs. Moreover, the medulla showed different alterations manifested as focal dystrophic calcification and intraluminal pale eosinophilic proteinaceous material in a focal manner. Raekallioet al. (2010) found similar results and proved that Ketoprofen can affect the renal tubules. Baisakhet al. (2014) recorded similar findings of administration of a therapeutic dose of Ibuprofen on renal tissue. Comparable findings were also seen by Talatet al. (2017) who studied the effect of Ibuprofen on renal tissue but their results were accompanied by no significant inflammatory reaction and mild glomerular congestion.Ketoprofen administration in this study showed multiple vascular changes.Owumi and Dim(2019) mentioned similar findings in their experimental studies on diclofenac sodium in kidney rats.

 

The kidneys are essential organs for the excretory function of the body hence; they receive about 25% of all cardiac output. They preserve homeostasis, metabolize and excrete a lot of exogenous substances, such as drugs(Rahman and Malcoun, 2014; Pathan et al., 2018; Lucaset al., 2019). Many research explained the action of Ketoprofen and its effect. As all NSAIDs, Ketoprofen acts by inhibiting the cyclooxygenase (COX) pathway of arachidonic acid (AA) metabolism(Kantor, 1986).Prostaglandins vasodilate the afferent arterioles of the glomeruli and maintain glomerular filtration rate (Patrono and Dunn, 1987; Oates et al., 1988). Inhibition of COX pathway and the protective effect of prostaglandin by NSAIDs leads to activation of the lipoxygenase pathway, also increase the formation of leukotrienes which act as mediators of inflammation(Rainsford, 2007; Pountoset al., 2011). Furthermore, NSAIDs cause a decrease in ability of the kidneys to autoregulate blood flow(Gunson, 1983; Clive and Stoff, 1984).

 

Moreover, the acute tubular injury occurred by 2 mechanisms. The first one is the inhibitory effect on prostaglandin synthesis by NSAIDs, this leads to vasoconstriction of afferent renal arteriole and acute renal injury. The second one is acute interstitial nephritis characterized by localized inflammatory response and edema of the renal interstitium causingimpairment in perfusion; this leads to renal cellular injury (Konder and Kudrimoti, 2003; Lucas et al., 2019).

 

In the present study, the Ketoprofen administered group after 2 and 4 weeks showed significant increase in values of urea and creatinine levels when compared with the control group.These findings were in agreement withRaekallioet al. (2010)who recorded an increase in plasma concentration of urea and creatinine when evaluated the effect of Ketoprofen on the urinary enzyme.Similar results were obtained by El-Fekyet al.(2018) who studied the effect of Ketoprofen on kidney functions. In addition, similar findings were reported byTalatet al.(2017) who stated the effect of Ibuprofen on kidney functions.

 

Urea and creatinine are metabolic waste products that are normally filtered by the glomeruli of the kidneys (Gaspariet al., 1998).NSAIDs are known to alter renal function by decreasing the glomerular filtration rate due to inhibition of prostaglandin synthesis, which leads to retention of urea, creatinine and other nitrogen waste products that are normally removed by the kidneys (Bennett et al., 1996; Bellomo et al., 2012; Aprioku and Uche, 2013; Paueksakon and Fogo, 2017; Luciano and Perazella, 2018). Hence, serum concentrations of urea and creatinine can indicate renal toxicity (Perroneet al., 1992; Traynoret al., 2006).By contrast, minimal changes in the levels of urea and creatinine were recorded byBorges et al.(2013).Muchharaet al. (2018)observednon-significant changes in serum urea and creatinine levels. Furthermore, Apriokuet al. (2014) mentioned that Ibuprofen administration to rats did not change serum levels of urea and creatinine in low and high doses at 7 days and in low dose at 14 days but these levels were increased in high dose at 14 and 28 days of the experiment.

 

In the current study, determination of serum levels of MDA and TAC proved that there was a significant elevation in the level of MDA in the Ketoprofen 2 and 4 weeks administered group than the control one. On the other hand, the serum level of TAC in the Ketoprofen 2 and 4 weeks administrated group was numerically decreased in comparison with the control group. Similar findings were described bymany authors who concluded that Ketoprofen alters oxidative stress markers (Fefaret al., 2016; El-Fekyet al., 2018; Deniz, 2019). Owumi and Dim (2019) studied the effect of diclofenac sodium on renal oxidative stress and recorded the same results.

 

There are various influences on oxidative stress and antioxidant-related parameters caused by NSAIDs (Orhan et al., 1999). In renal ischemia, a decrease in intracellular levels of adenosine triphosphate (ATP) and a rapid increase in reactive oxygen species production was happened (Edelstein et al., 1997; Dagher, 2000; Lee et al., 2005). Malondialdehyde (MDA) is a useful marker of free radical-mediated damage and oxidative stress; as an end product of lipid peroxidation (Del Rio et al., 2005). Lipid peroxidation is the most important source of free radicals to cause injury. These free radicals directly damage cellular membranes and produce several secondary products which lead to extensive cellular damage (Romero et al., 1998). Our observed results of antioxidant enzymes were supported by(Chenget al.,2013).

 

It could be concluded thatadministration of Ketoprofen for a short period in a therapeutic dose can cause various forms of nephropathic lesions in each of the glomeruli, tubules, and interstitium; furthermore, biochemical indices were also altered.

 

REFERENCES

 

Aprioku, J.S.;Nwidu, L.L. andAmadi, C.N. (2014): Evaluation of toxicological profile of ibuprofen in wistar albino rats. Am J Biomed Sci, 6(1), 32-40.‏

Arrioja-Dechert, A. (2002):Anafen Injection and Tablets (small animal) (Merial-Canada). Compendium of veterinary products, CD ed. Port Huron, MI: North American Compendiums, Inc.

Awad, D.S.; Ali, R.M.;Mhaidat, N.M. andShotar, A.M. (2014):Zizyphusjujuba protects against ibuprofen-induced nephrotoxicity in rats. Pharmaceutical Biology, 52(2), 182-186.

Baisakh, P.;Mohanty, B.B.;Agrawal, D.;Baisakh, M.R.;Dutta, B.K. andChinara, P.K. (2014): Effects of ibuprofen on kidneys of albino rats. Res J Pharm Biol Chem Sci, 5(5), 136-42.‏

Bancroft, J.D. and Stevens, A.I. (1982): Theory and Practice of Histological Techniques. 2nd. Churchill Livingston, 338-439.‏

Bellomo, R.;Kellum, J.A. andRonco, C. (2012): Acute kidney injury. The Lancet, 380(9843), 756-766.‏

Bennett, W.M.;Henrich, W.L. andStoff, J.S. (1996): The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. American Journal of Kidney Diseases, 28(1), S56-S62.‏

Borges, M.; Marini Filho, R.;Laposy, C.B.;Guimarães-Okamoto, P.T.C.; Chaves, M.P.; Vieira, A.N.L.S. andMelchert, A. (2013): Nonsteroidal anti-inflammatory therapy: changes on renal function of healthy dogs. ActaCirurgicaBrasileira, 28(12), 842-847.‏

Breyer, M.D. and Harris, R.C. (2001): Cyclooxygenase 2 and the kidney. Current opinion in nephrology and hypertension, 10(1), 89-98.‏

Caldwell, J.; Hutt, A.J. andFournel-Gigleux, S. (1988):The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochemical pharmacology, 37(1), 105-114.‏

Chen, J.;Ren, J.; Loo, W.T.; Hao, L. and Wang, M. (2018):Lysyl oxidases expression and histopathological changes of the diabetic rat nephron. Molecular Medicine Reports, 17(2), 2431-2441.‏

Cheng, Y.T.; Wu, C.H.; Ho, C.Y. and Yen, G.C. (2013):Catechin protects against Ketoprofen-induced oxidative damage of the gastric mucosa by up-regulating Nrf2 in vitro and in vivo. The Journal of Nutritional Biochemistry, 24(2), 475-483.‏

Clive, D.M. and Stoff, J.S. (1984):Renal syndromes associated with nonsteroidalantiinflammatory drugs. New England Journal of Medicine, 310(9), 563-572.‏

Dagher, P.C. (2000): Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools. American Journal of Physiology-Cell Physiology, 279(4), C1270-C1277.‏

Del Rio, D.; Stewart, A.J. and Pellegrini, N. (2005): A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, metabolism and cardiovascular diseases, 15(4), 316-328.‏

Deniz, G.Y. (2019): The protective effects of thymol against Ketoprofen induced damages on pancreatic acinar and islet of langerhans cells in rats. Journal of Essential Oil Bearing Plants, 22(3), 604-613.‏

Edelstein, C.L.; Ling, H. and Schrier, R.W. (1997):The nature of renal cell injury. Kidney international,51(5), 1341-1351.‏

El-Feky, A.M.;Elbatanony, M.M.;Naser, A.F.A. andHamed, M.A. (2018):A therapeutic insight of carbohydrate and fixed oil from Plantago ovata L. seeds against Ketoprofen-induced hepatorenal toxicity in rats. Bulletin of the National Research Centre, 42(1), 1-16.‏

Farag Allah, M. (2001):The side effects of the nonsteroidal anti-inflammatory drug (NSAID) Ketoprofen on histological and ultrastructural aspects of the kidneys of albino rats. The Egyptian Journal of Hospital Medicine, 3(1), 161-176.‏

Fawcett, J. and Scott, J. (1960):A rapid and precise method for the determination of urea. Journal of Clinical Pathology, 13(2), 156-159.‏

Fefar, D.T.;Khanpara, Y.J.; Joshi, D.V.; Patel, B.J.;Modi, S.K. andKalaria, V.A. (2016):Study on haemato-biochemical and oxidative stress in experimentally induced Ketoprofentoxicity in wistar rats. The indian Journal of Veterinary Science and Biotechnology, 12(01), 30-34.

Fries, J.F.; Williams, C.A.; Ramey, D. and Bloch, D.A. (1993):The relative toxicity of disease‐modifying antirheumatic drugs. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 36(3), 297-306.‏

Gaspari, F.;Perico, N.;Matalone, M.;Signorini, O.;Azzollini, N.; Mister, M. andRemuzzi, G. (1998): Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. Journal of the American Society of Nephrology, 9(2), 310-313.‏

Grecu, M.;Năstasă, V.;Ilie, C.;Miron, L. andMareş, M. (2014):Comparative assessment of effectiveness of Ketoprofen and Ketoprofen/beta-cyclodextrin complex in two experimental models of inflammation in rats. Laboratory Animals, 48(1), 20-26.‏

Gunson, D.E. (1983): Renal papillary necrosis in horses. Journal of the American Veterinary Medical Association, 182(3), 263-266.‏

Harirforoosh, S.;Asghar, W. and Jamali, F. (2013): Adverse effects of nonsteroidalantiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. Journal of Pharmacy & Pharmaceutical Sciences, 16(5), 821-847.‏

Kantor, T.G. (1986):Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 6(3), 93-102.

Kent, A.L.; Maxwell, L.E.;Koina, M.E.; Falk, M.C.;Willenborg, D. andDahlstrom, J.E. (2007): Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatric Research, 62(3), 307-312.

Klasco, R.K. (2003):USP DI Drug information for the healthcare professional. Volume III. Greenwood Village, CO: Thomson Micromedex, Inc.

Kodner, C. andKudrimoti, A. (2003): Diagnosis and management of acute interstitial nephritis. American Family Physician, 67(12), 2527-2534.‏

Koracevic, D.;Koracevic, G.;Djordjevic, V.;Andrejevic, S. andCosic, V. (2001): Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology, 54(5), 356-361.‏

Larsen, K. (1972): Creatinine assay by a reaction-kinetic principle. ClinicaChimicaActa, 41, 209-217.‏

Lee, Y.J.; Park, S.H.;Jeung, T.O.; Kim, K.W.;Lee, J.H. and Han, H.J. (2005): Effect of adenosine triphosphate on phosphate uptake in renal proximal tubule cells: involvement of PKC and p38 MAPK. Journal of Cellular Physiology, 205(1), 68-7.

Levoin, N.;Blondeau, C.; Guillaume, C.;Grandcolas, L.; Chretien, F.;Jouzeau, J.Y. andLapicque, F. (2004): Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of Ketoprofen. Biochemical Pharmacology, 68(10), 1957-1969.‏

Lucas, G.N.C.;Leitão, A.C.C.;Alencar, R.L.; Xavier, R.M.F.;Daher, E.D.F. and Silva Junior, G.B.D. (2019): Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. Brazilian Journal of Nephrology, 41(1), 124-130.‏

Luciano, R.L. andPerazella, M.A. (2018): Drug-induced acute kidney injury. In Core Concepts in Acute Kidney Injury (pp. 145-163). Springer, New York, NY.‏

Medeiros, R.S.; Ferreira, A.P.G.andCavalheiro, E.T.G. (2020): Thermal behavior of naproxen and Ketoprofennonsteroidal anti-inflammatory drugs. Journal of Thermal Analysis and Calorimetry, 1-11.‏

Mozaffari, A.A. andDerakhshanfar, A. (2011): Evaluation of the brain, renal, and hepatic effects of flunixinmeglumine, Ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep. Tropical animal health and production, 43(7), 1389-1393.‏

Mozaffari, A.A.;Derakhshanfar, A.; Alinejad, A. andMorovati, M. (2010):A comparative study on the adverse effects of flunixin, Ketoprofen and phenylbutazone in miniature donkeys: haematological, biochemical and pathological findings. New Zealand Veterinary Journal, 58(5), 224-228.‏

Muchhara, J.A.;Sankhala, L.N.;Champawat, M.;Bhavsar, S.K.;Thakar, A.M.;Dadhaniya, P.K.;and Patel, C.D. (2018):Evaluation of toxic potential of Ketoprofen on hemato-biochemical parameters following subacute intramuscular administration in wistar rats. International Journal of Science, Environment and Technology, Vol. 7, No 3, 2018, 925–932.

Oates, J.A.; FitzGerald, G.A.; Branch, R.A.; Jackson, E.K.; Knapp, H.R. and Roberts, L.J. (1988): Clinical implications of prostaglandin and thromboxane A2 formation. New England Journal of Medicine, 319(11), 689-698.‏

Ohkawa, H.;Ohishi, N. and Yagi, K. (1979): Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry,95(2), 351-358.‏

Orhan, H.;Ínanici, F.;Arslan, Ş.;Hasçelik, Z. andŞahin, Ö. (1999): In vivo effects of non-steroidal antiinflammatory drugs on oxidative stress-related parameters of human erythrocytes. Experimental and Toxicologic Pathology, 51(4-5), 403-408.‏

Owens, J.G.;Kamerling, S.G.; Stanton, S.R. andKeowen, M.L. (1995): Effects of Ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Veterinary Journal, 27(4), 296-300.‏

Owumi, S.E. and Dim, U.J. (2019): Biochemical alterations in diclofenac-treated rats: Effect of selenium on oxidative stress, inflammation, and hematological changes. Toxicology Research and Application, 3, 2397847319874359.‏

Pathan, S.A.;Mitra, B. and Cameron, P.A. (2018): A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic. European Urology, 73(4), 583-595.‏

Patrono, C. and Dunn, M.J. (1987):The clinical significance of inhibition of renal prostaglandin synthesis. Kidney International, 32(1), 1-12.‏

Paueksakon, P. and Fogo, A.B. (2017): Drug‐induced nephropathies. Histopathology, 70(1), 94-108.‏

Perrone, R.D.;Madias, N.E. and Levey, A.S. (1992): Serum creatinine as an index of renal function: new insights into old concepts. Clinical Cemistry, 38(10), 1933-1953.‏

Pountos, I.;Georgouli, T.; Bird, H. andGiannoudis, P.V. (2011):Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. International Journal of Interferon, Cytokine and Mediator Research, 3, 19-27.‏

Raekallio, M.R.;Saario-Paunio, E.M.;Rajamäki, M.M.;Sankari, S.M.;Palviainen, M.J.;Siven, M.S. andVainio, O.M. (2010): Early detection of Ketoprofen-induced acute kidney injury in sheep as determined by evaluation of urinary enzyme activities. American Journal of Veterinary Research, 71(10), 1246-1252.

Rahman, S. andMalcoun, A. (2014):Nonsteroidalantiinflammatory drugs, cyclooxygenase-2, and the kidneys. Primary Care: Clinics in Office Practice, 41(4), 803-821.‏

Rainsford, K.D. (2007): Anti-inflammatory drugs in the 21st century. Inflammation in the Pathogenesis of Chronic Diseases, 3-27.‏

Romero, F.J.; Bosch-Morell, F.; Romero, M.J.;Jareño, E.J.; Romero, B.; Marín, N. andRomá, J. (1998): Lipid peroxidation products and antioxidants in human disease. Environmental Health Perspectives,106(suppl 5), 1229-1234.‏

Safarchi, R.;Mozaffari, A.A.;Derakhshanfar, A. andMarvili, O.A. (2010): Evaluation of the effects of flunixinmeglumine, Ketoprofen and phenylbutazone administration on the brain, renal and hepatic functions in Iranian cross-breed goats. Journal of Biological Sciences, 10(2), 170-173.‏

Seymour, R.A.; Kelly, P.J. andHawkesford, J.E. (1996): The efficacy of Ketoprofen and paracetamol (acetaminophen) in postoperative pain after third molar surgery. British journal of clinical pharmacology, 41(6), 581-585.‏

Shpigel, N.Y.; Chen, R.; Winkler, M.; Saran, A.; Ziv, G. and Longo, F. (1994): Anti-inflammatory Ketoprofen in the treatment of field cases of bovine mastitis. Research in Veterinary Science, 56(1), 62-68.‏

Talat Abbas, M.;Murtadha Abed, R. andJabarMetab, N. (2017): The effect of olive oil on ibuprofen induced renal toxicity in female rats. Karbala Journal of Pharmaceutical Sciences, 8(13), 167-177.‏

Tomic, Z.;Milijasevic, B.; Sabo, A.;Dusan, L.;Jakovljevic, V.;Mikov, M. andVasovic, V. (2008):Diclofenac and Ketoprofen liver toxicity in rat. European Journal of Drug Metabolism and Pharmacokinetics, 33(4), 253-260.‏

Traynor, J.;Mactier, R.; Geddes, C.C. and Fox, J.G. (2006): How to measure renal function in clinical practice. Bmj, 333(7571), 733-737.‏

Villegas, I.; La Casa, C.; de la Lastra, C.A.;Motilva, V.;Herrerı́as, J.M. andMartı́n, M.J. (2004):Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response. Life Sciences, 74(7), 873-884.‏

Zafar, F.; Ali, H.;Naqvi, G.R.; Khan, S.;Qureshi, M.S. and Sharif, H. (2017):Ketoprofen. The Professional Medical Journal, 24(01), 10-13.

 

‏       

 

 

 

 

 

            التغيراتالنسيجيةالمرضيةوالبيوکيميائية للآفات الکلوية الحادة الناجمة عن الکيتوبروفين

فيالجرذان

 

اميره سيد صادق، مروه فاروق على ، سارى خليل عبد الغفار ، مختار طه

 

Email: amira.sayed4494@gmail.comAssiut University web-site: www.aun.edu.eg

 

 

تمإجراءالعملالحاليلتقييمالتأثيرالکلويللکيتوبروفينعلىذکورالجرذانالبالغة. تمتقسيمثمانيةعشرا جرذاإلىمجموعتين. تمإعطاءکيتوبروفينللمجموعة (I) التيتضمنت10جرذانبجرعةعلاجية 13.5 مجم / کجمعنطريقالحقنالعضلى يوميًالمدة 4 أسابيعمتتالية. تماختيارخمسةجرذان بشکلعشوائيمنالمجموعةالأولىحيث تمالتضحيةبهابعد اسبوعين و بعد4 أسابيعمنالتجربة. ضمتالمجموعةالضابطة (II) التيتلقتزيتالزيتون 8 جرذان ،حيثتمالتضحيةبـ 4 جرذان بعدأسبوعينوتمالتضحيةببقيةالجرذانبعد 4 أسابيع. تمجمععيناتأنسجةالکلىمنجميعالمجموعاتللفحصالتشريحيالمرضيوکذلکتمالحصولعلىمصلالدملتحديدالمعاييرالبيوکيميائية. أظهرالفحصالنسيجيالمرضيللمجموعةالأولىتغيراتکبيبيةمثلتمددالمصفوفةالکبيبية والتصلب الکبيبىواحتقانالشعيراتالدمويةالکبيبيةفيالقشرة. کمالوحظتنکسونخر کلويأنبوبيمصحوببارتشاح الخلاياالالتهابيةفيالنسيجالخلاليفيکلمنالقشرةوالنخاع. أظهرتالنتائجالبيوکيميائيةأنالحيواناتفيالمجموعةالأولىأظهرتزيادةمعنويةفي الملانوندايالدهيدوالکرياتينينواليوريامقارنةبالمجموعةالضابطة،بينما انخفضتالسعةالکليةلمضاداتالأکسدةعدديًا. فيالختام،تسببتالجرعةالعلاجيةمنکيتوبروفينفيتلفأنسجةالکلىحتىلوتمتناولهالفترةقصيرةبالإضافةإلىتغيير فيالمعايير البيوکيميائية.

 

 

 
REFERENCES
 
Aprioku, J.S.;Nwidu, L.L. andAmadi, C.N. (2014): Evaluation of toxicological profile of ibuprofen in wistar albino rats. Am J Biomed Sci, 6(1), 32-40.‏
Arrioja-Dechert, A. (2002):Anafen Injection and Tablets (small animal) (Merial-Canada). Compendium of veterinary products, CD ed. Port Huron, MI: North American Compendiums, Inc.
Awad, D.S.; Ali, R.M.;Mhaidat, N.M. andShotar, A.M. (2014):Zizyphusjujuba protects against ibuprofen-induced nephrotoxicity in rats. Pharmaceutical Biology, 52(2), 182-186.
Baisakh, P.;Mohanty, B.B.;Agrawal, D.;Baisakh, M.R.;Dutta, B.K. andChinara, P.K. (2014): Effects of ibuprofen on kidneys of albino rats. Res J Pharm Biol Chem Sci, 5(5), 136-42.‏
Bancroft, J.D. and Stevens, A.I. (1982): Theory and Practice of Histological Techniques. 2nd. Churchill Livingston, 338-439.‏
Bellomo, R.;Kellum, J.A. andRonco, C. (2012): Acute kidney injury. The Lancet, 380(9843), 756-766.‏
Bennett, W.M.;Henrich, W.L. andStoff, J.S. (1996): The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. American Journal of Kidney Diseases, 28(1), S56-S62.‏
Borges, M.; Marini Filho, R.;Laposy, C.B.;Guimarães-Okamoto, P.T.C.; Chaves, M.P.; Vieira, A.N.L.S. andMelchert, A. (2013): Nonsteroidal anti-inflammatory therapy: changes on renal function of healthy dogs. ActaCirurgicaBrasileira, 28(12), 842-847.‏
Breyer, M.D. and Harris, R.C. (2001): Cyclooxygenase 2 and the kidney. Current opinion in nephrology and hypertension, 10(1), 89-98.‏
Caldwell, J.; Hutt, A.J. andFournel-Gigleux, S. (1988):The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochemical pharmacology, 37(1), 105-114.‏
Chen, J.;Ren, J.; Loo, W.T.; Hao, L. and Wang, M. (2018):Lysyl oxidases expression and histopathological changes of the diabetic rat nephron. Molecular Medicine Reports, 17(2), 2431-2441.‏
Cheng, Y.T.; Wu, C.H.; Ho, C.Y. and Yen, G.C. (2013):Catechin protects against Ketoprofen-induced oxidative damage of the gastric mucosa by up-regulating Nrf2 in vitro and in vivo. The Journal of Nutritional Biochemistry, 24(2), 475-483.‏
Clive, D.M. and Stoff, J.S. (1984):Renal syndromes associated with nonsteroidalantiinflammatory drugs. New England Journal of Medicine, 310(9), 563-572.‏
Dagher, P.C. (2000): Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools. American Journal of Physiology-Cell Physiology, 279(4), C1270-C1277.‏
Del Rio, D.; Stewart, A.J. and Pellegrini, N. (2005): A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, metabolism and cardiovascular diseases, 15(4), 316-328.‏
Deniz, G.Y. (2019): The protective effects of thymol against Ketoprofen induced damages on pancreatic acinar and islet of langerhans cells in rats. Journal of Essential Oil Bearing Plants, 22(3), 604-613.‏
Edelstein, C.L.; Ling, H. and Schrier, R.W. (1997):The nature of renal cell injury. Kidney international,51(5), 1341-1351.‏
El-Feky, A.M.;Elbatanony, M.M.;Naser, A.F.A. andHamed, M.A. (2018):A therapeutic insight of carbohydrate and fixed oil from Plantago ovata L. seeds against Ketoprofen-induced hepatorenal toxicity in rats. Bulletin of the National Research Centre, 42(1), 1-16.‏
Farag Allah, M. (2001):The side effects of the nonsteroidal anti-inflammatory drug (NSAID) Ketoprofen on histological and ultrastructural aspects of the kidneys of albino rats. The Egyptian Journal of Hospital Medicine, 3(1), 161-176.‏
Fawcett, J. and Scott, J. (1960):A rapid and precise method for the determination of urea. Journal of Clinical Pathology, 13(2), 156-159.‏
Fefar, D.T.;Khanpara, Y.J.; Joshi, D.V.; Patel, B.J.;Modi, S.K. andKalaria, V.A. (2016):Study on haemato-biochemical and oxidative stress in experimentally induced Ketoprofentoxicity in wistar rats. The indian Journal of Veterinary Science and Biotechnology, 12(01), 30-34.
Fries, J.F.; Williams, C.A.; Ramey, D. and Bloch, D.A. (1993):The relative toxicity of disease‐modifying antirheumatic drugs. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 36(3), 297-306.‏
Gaspari, F.;Perico, N.;Matalone, M.;Signorini, O.;Azzollini, N.; Mister, M. andRemuzzi, G. (1998): Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. Journal of the American Society of Nephrology, 9(2), 310-313.‏
Grecu, M.;Năstasă, V.;Ilie, C.;Miron, L. andMareş, M. (2014):Comparative assessment of effectiveness of Ketoprofen and Ketoprofen/beta-cyclodextrin complex in two experimental models of inflammation in rats. Laboratory Animals, 48(1), 20-26.‏
Gunson, D.E. (1983): Renal papillary necrosis in horses. Journal of the American Veterinary Medical Association, 182(3), 263-266.‏
Harirforoosh, S.;Asghar, W. and Jamali, F. (2013): Adverse effects of nonsteroidalantiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. Journal of Pharmacy & Pharmaceutical Sciences, 16(5), 821-847.‏
Kantor, T.G. (1986):Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 6(3), 93-102.
Kent, A.L.; Maxwell, L.E.;Koina, M.E.; Falk, M.C.;Willenborg, D. andDahlstrom, J.E. (2007): Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatric Research, 62(3), 307-312.
Klasco, R.K. (2003):USP DI Drug information for the healthcare professional. Volume III. Greenwood Village, CO: Thomson Micromedex, Inc.
Kodner, C. andKudrimoti, A. (2003): Diagnosis and management of acute interstitial nephritis. American Family Physician, 67(12), 2527-2534.‏
Koracevic, D.;Koracevic, G.;Djordjevic, V.;Andrejevic, S. andCosic, V. (2001): Method for the measurement of antioxidant activity in human fluids. Journal of Clinical Pathology, 54(5), 356-361.‏
Larsen, K. (1972): Creatinine assay by a reaction-kinetic principle. ClinicaChimicaActa, 41, 209-217.‏
Lee, Y.J.; Park, S.H.;Jeung, T.O.; Kim, K.W.;Lee, J.H. and Han, H.J. (2005): Effect of adenosine triphosphate on phosphate uptake in renal proximal tubule cells: involvement of PKC and p38 MAPK. Journal of Cellular Physiology, 205(1), 68-7.
Levoin, N.;Blondeau, C.; Guillaume, C.;Grandcolas, L.; Chretien, F.;Jouzeau, J.Y. andLapicque, F. (2004): Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of Ketoprofen. Biochemical Pharmacology, 68(10), 1957-1969.‏
Lucas, G.N.C.;Leitão, A.C.C.;Alencar, R.L.; Xavier, R.M.F.;Daher, E.D.F. and Silva Junior, G.B.D. (2019): Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. Brazilian Journal of Nephrology, 41(1), 124-130.‏
Luciano, R.L. andPerazella, M.A. (2018): Drug-induced acute kidney injury. In Core Concepts in Acute Kidney Injury (pp. 145-163). Springer, New York, NY.‏
Medeiros, R.S.; Ferreira, A.P.G.andCavalheiro, E.T.G. (2020): Thermal behavior of naproxen and Ketoprofennonsteroidal anti-inflammatory drugs. Journal of Thermal Analysis and Calorimetry, 1-11.‏
Mozaffari, A.A. andDerakhshanfar, A. (2011): Evaluation of the brain, renal, and hepatic effects of flunixinmeglumine, Ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep. Tropical animal health and production, 43(7), 1389-1393.‏
Mozaffari, A.A.;Derakhshanfar, A.; Alinejad, A. andMorovati, M. (2010):A comparative study on the adverse effects of flunixin, Ketoprofen and phenylbutazone in miniature donkeys: haematological, biochemical and pathological findings. New Zealand Veterinary Journal, 58(5), 224-228.‏
Muchhara, J.A.;Sankhala, L.N.;Champawat, M.;Bhavsar, S.K.;Thakar, A.M.;Dadhaniya, P.K.;and Patel, C.D. (2018):Evaluation of toxic potential of Ketoprofen on hemato-biochemical parameters following subacute intramuscular administration in wistar rats. International Journal of Science, Environment and Technology, Vol. 7, No 3, 2018, 925–932.
Oates, J.A.; FitzGerald, G.A.; Branch, R.A.; Jackson, E.K.; Knapp, H.R. and Roberts, L.J. (1988): Clinical implications of prostaglandin and thromboxane A2 formation. New England Journal of Medicine, 319(11), 689-698.‏
Ohkawa, H.;Ohishi, N. and Yagi, K. (1979): Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry,95(2), 351-358.‏
Orhan, H.;Ínanici, F.;Arslan, Ş.;Hasçelik, Z. andŞahin, Ö. (1999): In vivo effects of non-steroidal antiinflammatory drugs on oxidative stress-related parameters of human erythrocytes. Experimental and Toxicologic Pathology, 51(4-5), 403-408.‏
Owens, J.G.;Kamerling, S.G.; Stanton, S.R. andKeowen, M.L. (1995): Effects of Ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Veterinary Journal, 27(4), 296-300.‏
Owumi, S.E. and Dim, U.J. (2019): Biochemical alterations in diclofenac-treated rats: Effect of selenium on oxidative stress, inflammation, and hematological changes. Toxicology Research and Application, 3, 2397847319874359.‏
Pathan, S.A.;Mitra, B. and Cameron, P.A. (2018): A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic. European Urology, 73(4), 583-595.‏
Patrono, C. and Dunn, M.J. (1987):The clinical significance of inhibition of renal prostaglandin synthesis. Kidney International, 32(1), 1-12.‏
Paueksakon, P. and Fogo, A.B. (2017): Drug‐induced nephropathies. Histopathology, 70(1), 94-108.‏
Perrone, R.D.;Madias, N.E. and Levey, A.S. (1992): Serum creatinine as an index of renal function: new insights into old concepts. Clinical Cemistry, 38(10), 1933-1953.‏
Pountos, I.;Georgouli, T.; Bird, H. andGiannoudis, P.V. (2011):Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. International Journal of Interferon, Cytokine and Mediator Research, 3, 19-27.‏
Raekallio, M.R.;Saario-Paunio, E.M.;Rajamäki, M.M.;Sankari, S.M.;Palviainen, M.J.;Siven, M.S. andVainio, O.M. (2010): Early detection of Ketoprofen-induced acute kidney injury in sheep as determined by evaluation of urinary enzyme activities. American Journal of Veterinary Research, 71(10), 1246-1252.
Rahman, S. andMalcoun, A. (2014):Nonsteroidalantiinflammatory drugs, cyclooxygenase-2, and the kidneys. Primary Care: Clinics in Office Practice, 41(4), 803-821.‏
Rainsford, K.D. (2007): Anti-inflammatory drugs in the 21st century. Inflammation in the Pathogenesis of Chronic Diseases, 3-27.‏
Romero, F.J.; Bosch-Morell, F.; Romero, M.J.;Jareño, E.J.; Romero, B.; Marín, N. andRomá, J. (1998): Lipid peroxidation products and antioxidants in human disease. Environmental Health Perspectives,106(suppl 5), 1229-1234.‏
Safarchi, R.;Mozaffari, A.A.;Derakhshanfar, A. andMarvili, O.A. (2010): Evaluation of the effects of flunixinmeglumine, Ketoprofen and phenylbutazone administration on the brain, renal and hepatic functions in Iranian cross-breed goats. Journal of Biological Sciences, 10(2), 170-173.‏
Seymour, R.A.; Kelly, P.J. andHawkesford, J.E. (1996): The efficacy of Ketoprofen and paracetamol (acetaminophen) in postoperative pain after third molar surgery. British journal of clinical pharmacology, 41(6), 581-585.‏
Shpigel, N.Y.; Chen, R.; Winkler, M.; Saran, A.; Ziv, G. and Longo, F. (1994): Anti-inflammatory Ketoprofen in the treatment of field cases of bovine mastitis. Research in Veterinary Science, 56(1), 62-68.‏
Talat Abbas, M.;Murtadha Abed, R. andJabarMetab, N. (2017): The effect of olive oil on ibuprofen induced renal toxicity in female rats. Karbala Journal of Pharmaceutical Sciences, 8(13), 167-177.‏
Tomic, Z.;Milijasevic, B.; Sabo, A.;Dusan, L.;Jakovljevic, V.;Mikov, M. andVasovic, V. (2008):Diclofenac and Ketoprofen liver toxicity in rat. European Journal of Drug Metabolism and Pharmacokinetics, 33(4), 253-260.‏
Traynor, J.;Mactier, R.; Geddes, C.C. and Fox, J.G. (2006): How to measure renal function in clinical practice. Bmj, 333(7571), 733-737.‏
Villegas, I.; La Casa, C.; de la Lastra, C.A.;Motilva, V.;Herrerı́as, J.M. andMartı́n, M.J. (2004):Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response. Life Sciences, 74(7), 873-884.‏
Zafar, F.; Ali, H.;Naqvi, G.R.; Khan, S.;Qureshi, M.S. and Sharif, H. (2017):Ketoprofen. The Professional Medical Journal, 24(01), 10-13.